Institutional Ownership Aim Immuno Tech Inc. (AIM)
This table provides information about the institutional ownership of Aim Immuno Tech Inc. (AIM). We have compiled data on the 32 institutions that hold shares in the stock, with a total of 4.77 Million shares, which have been reported (via 13F filing form) to have a value of $42.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Steward Partners Investment Advisory, LLC
|
May 13, 2025 Q1 2025 |
220
shares
|
$1,951
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Td Waterhouse Canada Inc.
Toronto, A6 |
May 09, 2025 Q1 2025 |
170
shares
|
$1,507
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
127
shares
|
$1,126
0.0% of portfolio
|
Q1 2025
Reduced 7.97%
|
|
|
Huntington National Bank
Columbus, OH |
May 14, 2025 Q1 2025 |
57
shares
|
$505
0.0% of portfolio
|
Q4 2019
New holding
|
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
27
shares
|
$239
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Cwm, LLC
|
May 01, 2025 Q1 2025 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|